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isolation by a novel method (RIN > 6 = 70%, 260/280: 1.8∼2.0 = 100%,
260/230 > 1.0 = 95% (n=50)) and morphometry calculation by μCT (OA
n=20, non-OA normal n=2), Illumina microarray was performed (OA n=10,
non-OA normal n=2) and real-time quantitative polymerase chain reaction
was executed for data validation (OA n=20, non-OA normal n=2).
Results: A total of 205 transcripts were found be expressed at signiﬁcantly
different level among the regions. Most of these genes related to the
extracellular matrix synthesis, cell proliferation, bone cell differentiation.
These genes might play key roles in breakdown of subchondral bone
homeostasis in OA.
Conclusions: The novel USB RNA isolation methodical approach reported
here not only allows to determine area-speciﬁc gene proﬁles in knee
specimen. In addition, this study also show some genes might play a role
in OA bone remodeling.
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Human bone cells derived from bone marrow (BM) aspirates or trabecular
bone (TB) tissue have been used for studies of bone biology. However,
an in-vitro characterization of these cells is necessary not only for basic
studies in health and disease but also for cellular therapies for tissue repair.
Bone tissue is often discarded during joint replacement or bone correction
surgery and this tissues could represent a good potential alternative source
of osteoprogenitor cells for tissue engineering purposes. The study aims
to validate the potential of different bone cells obtained from the same
anatomical site. Therefore, we isolated MSCs from BM and osteoblasts (OBs)
from tibia of healthy and OA patients. MSCs and OBs were compared for
growth conditions, cell proliferation, phenotype and osteogenic potential.
MSCs and OBs were grown both in α-MEM and DMEM/F12 medium. We
found that MSCs were able to grow only in α-MEM while OBs could survive
and proliferate in both medium tested. The proliferation of healthy MSC and
OB grown in α-MEM was signiﬁcantly higher than OA MSC and OB, while
no signiﬁcant differences were observed in OB grown in DMEM/F12. Flow
cytometric analysis for CD73, CD90, CD105, CD146, alkaline phosphatase,
bone sialoprotein (BSP) and collagen type I did not show differences among
the groups analysed. The osteogenic potential of MSC and OB grown in
α-MEM were next tested inducing the cells to differentiate along the
osteoblast lineage in osteogenic medium and demonstrating the positive
staining for extracellular calcium deposition at day 28. Real time PCR
analysis demonstrated a decrease expression of alkaline phosphatase and
collagen type I associated with an increase of collagen type XV from Day 0
to day 28, while BSP expression was signiﬁcantly increased only in healthy
MSC and OA OB but not in OA MSC. Osteogenic control experiments were
also performed using MSC from iliac crest. Here, we found a decreased
expression of alkaline phosphatase and collagen type I from day 0 to day
28 and a signiﬁcant increase in collagen type XV and BSP expression. These
data suggest that even if osteogenic differentiation occurs in MSC and OB
from OA patients, OA OB were skewed towards a pattern of expression of
speciﬁc osteogenic markers more similar to that found in canonical BM
MSC.
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SMAD2/3 SIGNALING IS CRUCIAL FOR CARTILAGE MAINTENANCE,
WHEREAS SMAD1/5/8 SIGNALING DETERMINES CHONDROCYTE
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Purpose: In osteoarthritis (OA), chondrocyte behavior seems a recapit-
ulation of the developmental process. Chondrocytes loose their articular
cartilage phenotype and progress into a state highly similar to chondrocyte
hypertrophy, overexpressing MMP13. We have previously shown that dur-
ing OA, the balance between the TGF-beta receptors ALK1 and ALK5 shifts,
favoring the ALK1 receptor. Downstream this leads to a shift from signaling
via Smad2/3 towards Smad1/5/8, thereby favoring the signaling pathway
that is important in terminal differentiation. As a consequence, blocking of
the Smad1/5/8 pathway in differentiating chondrocytes might be a tool to
inhibit chondrocytes terminal differentiation.
We show that Smad1/5/8P expression is correlated with MMP13 expression
in limb formation and in terminally differentiated pellet cultures. More-
over, whereas blocking Smad2/3P halted further chondrogenesis, we show
that blocking the Smad1/5/8 pathway blocked terminal differentiation and
therefore inhibited chondrocyte hypertrophy.
Methods: BMSC were chondrogenically differentiated in pellet culture
in chondrogenic medium including TGF-β2. SB-505124 was added to in-
hibit Smad2/3 phosphorylation, while dorsomorphin was added to inhibit
Smad1/5/8 phosphorylation.
Immunohistochemistry and gene-expression analysis was performed for
markers of chondrogenic and terminal differentiation, as well as for
Smad2/3P and Smad1/5/8P. The ability to mineralize the tissue-engineered
constructs was studied in-vitro by adding 10 mM β-glycerophosphate (BGP)
to the medium.
Results: In pellet cultures of terminally differentiated BMSCs as well as
well as during embryonic limb formation, terminally differentiated chon-
drocytes were positive for both Smad2/3P and Smad1/5/8P. On the other
hand, hyaline-like cartilage that lacks expression of MMP13 and collagen X
did not express Smad1/5/8P, but expressed Smad2/3P.
To investigate whether both pathways were important during onset of
chondrogenesis, SB-505124 or dorsomorphin were added throughout the
culture period. This resulted in lack of collagen II expression, suggest-
ing that both pathways are involved in early chondrogenesis. However,
when the chondrocytes were given the opportunity to ﬁrst differentiate
towards a cartilage phenotype for 14 days and thereafter either Smad2/3
or Smad1/5/8 phosphorylation were blocked until day 35 distinct functions
were demonstrated.
Blocking Smad2/3phosphorylation from day 14-35 resulted in a halt in
collagen II production, whereas blocking Smad1/5/8phosphorylation de-
creased the expression of MMP13, collagen X and alkaline phosphatase
without inhibiting further collagen II production. Blocking Smad1/5/8phos-
phorylationcompletely prevented mineralization (Figure 1).
Figure 1. Alizarine Red staining demonstrating mineralization in control pellets (A), and
no mineralization in pellets treated with dorsomorphin from day 14 on (B).
Conclusions: Our data show that both the Smad2/3 and Smad1/5/8 path-
way are important for initial chondrogenesis in vitro. Blocking Smad2/3
after onset of chondrogenesis halts further collagen type II production
suggesting this pathway is crucial for cartilage maintenance. In contrast,
blocking Smad1/5/8 phosphorylation totally prevents terminal differentia-
tion as the expression of MMP13, collagen X and Alkaline phosphatase are
inhibited.
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WNT-6 INDUCES THE CHONDROGENIC DIFFERENTIATION OF
MESENCHYMAL STEM CELLS
C. Bony, D. Guerit, C. Jorgensen Sr., D. Noel Sr.
Inserm, Montpellier, France
Purpose: Mesenchymal stem cells (MSC) are suitable sources for cell-based
therapies in tissue engineering thanks to their capacities of differentiation
towards several lineages of the skeletal tissue. In particular, their potential
to differentiate into chondrocytes makes them attractive for cartilage re-
pair. However, regeneration of a fully functional and mature tissue will rely
on the use of an optimal combination of scaffold and differentiation factor.
Identiﬁcation of a factor that may induce the chondrocytic lineage and
